arrow
L

Lars G. Hemkens

research center for clinical neuroimmunology and neuroscience basel
H指数:45
被引数:8,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial

ctDNA用于指导晚期实体癌患者决策的混合方法过程评估: LIQPLAT试验子研究的研究方案

2025-10-270
OA
Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)

单剂量与3天抗菌药物预防在经尿道前列腺切除或光选择性汽化术中的应用:一项多中心、随机、安慰剂对照试验(CITrUS试验)

2025-09-120
PREAI
Retrospective use of the PRECIS-2 trial design tool to assess design choices in randomised controlled trials; An empirical review

运用PRECIS-2试验设计工具对随机对照试验的设计选择进行回顾性评估;一项实证综述

2025-09-010
OAAI
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response

血清神经丝轻链在多发性硬化中的研究:年龄和BMI校正的Z分数/百分位数对预测治疗反应优于绝对截断值

2025-08-030
OAAI
Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis

基层医疗中抗生素处方的审计与反馈干预:系统综述与meta分析

2024-12-052
PRE
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis

血清胶质纤维酸性蛋白和神经丝轻链水平反映了多发性硬化b细胞耗竭治疗下疾病进展的不同机制

2024-10-164
OA
Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review
2024-10-011
PRE